drugset / Trial / NCT00870441

Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers

NCT00870441

Phase 1 Terminated 442 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blind

Summary

The objective of the study is to compare the safety of ASP2151 to valacyclovir and placebo in healthy male and female adult volunteers.

Timeline

Start
2009-03
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amenamevir Small molecule Oral
Comparator Valacyclovir Unknown Oral

Indications

No indication recorded.